Skip to main navigation Skip to search Skip to main content

Cardiac Function and Serum Biomarkers throughout Staged Fontan Palliation: A Prospective Observational Study

  • J. P. G. van der Ven
  • , V. P. Kamphuis
  • , E. van den Bosch
  • , D. Gnanam
  • , C. Terol
  • , A. J. J. C. Bogers
  • , J. M. P. J. Breur
  • , R. M. F. Berger
  • , N. A. Blom
  • , A. D. J. ten Harkel
  • , L. Koopman
  • , W. A. Helbing*
  • *Corresponding author for this work
  • Erasmus University Rotterdam
  • Interuniversity Cardiology Institute of the Netherlands
  • Erasmus MC
  • Leiden University Medical Center
  • University Medical Center Utrecht
  • University of Groningen, University Medical Center Groningen

Research output: Contribution to journalArticleAcademicpeer-review

18 Downloads (Pure)

Abstract

Fontan patients undergo multiple cardiothoracic surgeries in childhood. Following these procedures, ventricular function is temporarily decreased, and recovers over months. This is presumably related to cardiopulmonary bypass, but this is incompletely understood. Throughout the Fontan palliation, cardiac function is also affected by volume unloading. We aimed to gain insight into the biological processes related to impaired ventricular function and recovery following Fontan palliations using a panel of biomarkers. Furthermore, we described changes in ventricular function across the Fontan palliation due to volume unloading. We performed a prospective multicenter observational study in patients undergoing partial (PCPC) or total cavo-pulmonary connection (TCPC). Patients underwent assessment—including echocardiography and blood sampling—before surgery (T1), at first follow-up (T2), and 1 year after their procedures (T3). Blood samples were analyzed using a biomarker panel (OLINK CVD-III). Ninety-two biomarkers were expressed as principal components (PC) to limit multiple statistical testing. We included 32 PCPC patients aged 7.2 [5.3–10.3] months, and 28 TCPC patients aged 2.7 [2.2–3.8] years. The single ventricular longitudinal strain (SV GLS) temporarily decreased for PCPC patients at T2 (−15.1 ± 5.6 (T1) to −13.5 ± 5.2 (T2) to −17.3 ± 4.5 (T3), p < 0.047 for all differences), but not following TCPC. The serum biomarkers were expressed as 4 PCs. PC1, including biomarkers of cell–cell adhesion, was not related to any patient characteristic. PC2, including biomarkers of superoxide anion regulation, increased at T2. PC3, including biomarkers of cardiovascular development, related to the stage of Fontan palliation. PC4 was of uncertain biological or clinical significance. No PC was found that related to ventricular performance. The SV GLS was temporarily diminished following PCPC, but not following TCPC. Several biomarkers were related to post-operative stress and adaptation to the PCPC or TCPC circulation, but none were related to the outcome.

Original languageEnglish
Article number289
JournalJournal of cardiovascular development and disease
Volume10
Issue number7
DOIs
Publication statusPublished - 1 Jul 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Fontan palliation
  • biomarkers
  • congenital heart disease
  • single ventricle

Fingerprint

Dive into the research topics of 'Cardiac Function and Serum Biomarkers throughout Staged Fontan Palliation: A Prospective Observational Study'. Together they form a unique fingerprint.

Cite this